These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16409567)

  • 41. Oral versus topical diclofenac for pain prevention during panretinal photocoagulation.
    Zakrzewski PA; O'Donnell HL; Lam WC
    Ophthalmology; 2009 Jun; 116(6):1168-74. PubMed ID: 19376588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of the asthma treatment satisfaction measure.
    Martin ML; Patrick DL; Bushnell DM; Meltzer EO; Gutierrez B; Parasuraman B
    Curr Med Res Opin; 2009 Oct; 25(10):2495-506. PubMed ID: 19689222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Browning DJ
    Am J Ophthalmol; 2005 Jul; 140(1):127-8. PubMed ID: 16038654
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparison of laser treatment of patients with the replace with "computer-based laser" between experienced and unexperienced operators].
    Starnawska AJ; Schneider U; Hasler PW
    Klin Monbl Augenheilkd; 2012 Dec; 229(12):1223-6. PubMed ID: 23196811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laser coagulation in the treatment of diabetic retinopathy].
    Mirzabekova KA
    Vestn Oftalmol; 2004; 120(4):41-4. PubMed ID: 15384852
    [No Abstract]   [Full Text] [Related]  

  • 46. Visual prosthetic device for bilateral end-stage macular degeneration.
    Chun DW; Heier JS; Raizman MB
    Expert Rev Med Devices; 2005 Nov; 2(6):657-65. PubMed ID: 16293092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of diabetic retinopathy on health-related quality of life.
    Sharma S; Oliver-Fernandez A; Liu W; Buchholz P; Walt J
    Curr Opin Ophthalmol; 2005 Jun; 16(3):155-9. PubMed ID: 15870571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy.
    Rofail D; Sherman S; Hartford C; Levine A; Baldasaro J; Marquis P; Rao R; Do DV
    Adv Ther; 2023 Apr; 40(4):1773-1786. PubMed ID: 36848017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychological, social and everyday visual impact of diabetic macular oedema and diabetic retinopathy: a systematic review.
    Cooper OAE; Taylor DJ; Crabb DP; Sim DA; McBain H
    Diabet Med; 2020 Jun; 37(6):924-933. PubMed ID: 31479552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The nurse's role in helping patients cope with sight loss.
    Browne M
    Nurs Times; 2003 Dec 2-8; 99(48):30-2. PubMed ID: 14705546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of diabetic retinopathy on quality of life].
    Shao Y; Li XR
    Zhonghua Yan Ke Za Zhi; 2008 Jul; 44(7):660-3. PubMed ID: 19040084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Side-effects and complications of laser treatment in diabetic retinal disease.
    Deschler EK; Sun JK; Silva PS
    Semin Ophthalmol; 2014; 29(5-6):290-300. PubMed ID: 25325854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Monitoring and therapy of patients with diabetic retinopathy at the Eye Clinic in Brno].
    Janula J; Titzová I
    Cesk Oftalmol; 1989 Mar; 45(2):91-4. PubMed ID: 2713923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL.
    Woodcock A; Bradley C; Plowright R; ffytche T; Kennedy-Martin T; Hirsch A
    Patient Educ Couns; 2004 Jun; 53(3):365-83. PubMed ID: 15186876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supports and barriers as experienced by individuals with vision loss from diabetes.
    Kaminsky TA; Mitchell PH; Thompson EA; Dudgeon BJ; Powell JM
    Disabil Rehabil; 2014; 36(6):487-96. PubMed ID: 23781911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of diabetic eye disease.
    Canning C
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():128. PubMed ID: 10450367
    [No Abstract]   [Full Text] [Related]  

  • 57. Utilities associated with diabetic retinopathy: results from a Canadian sample.
    Sharma S; Oliver-Fernandez A; Bakal J; Hollands H; Brown GC; Brown MM
    Br J Ophthalmol; 2003 Mar; 87(3):259-61. PubMed ID: 12598432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tailoring pan-retinal photocoagulation for the haemianopic patient.
    Rubinstein A; Porter N; Chen SD; Fletcher EC; Downes SM
    Eye (Lond); 2006 Mar; 20(3):396-7. PubMed ID: 15846387
    [No Abstract]   [Full Text] [Related]  

  • 59. [KTP laser coagulation for xanthelasma palpebrarum].
    Berger C; Kopera D
    J Dtsch Dermatol Ges; 2005 Oct; 3(10):775-9. PubMed ID: 16194155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project.
    Fenwick EK; Pesudovs K; Khadka J; Dirani M; Rees G; Wong TY; Lamoureux EL
    Qual Life Res; 2012 Dec; 21(10):1771-82. PubMed ID: 22290480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.